COHANCE.BO

Cohance Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$426.80

Jun 12, 2026

AI Brief

Market cap

$164.06B

52w range

—

P / E

—

EPS · FY 2026

$4.68

Volume

—

Revenue · FY 2026

$22.69B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Financials Ratios Multiples Segments Profile

Explain this page

Arphra AIPlain-English read on Cohance Lifesciences Limited’s valuation

Business description

· company · SEC profile

Cohance Lifesciences Limited

Headquartered in Hyderabad, Cohance Lifesciences Limited is a pharmaceutical company with a core focus on providing contract development and manufacturing (CDMO) services, developing active pharmaceutical ingredients (APIs), and manufacturing specialty chemicals. This entity was formerly known as Suven Pharmaceuticals Limited but underwent a rebranding to its current name following its integration with Cohance Lifesciences, a transition that became effective on May 1, 2025.

Founded

—

IPO

Mar 09, 2020

Employees

2,576

Hyderabad

CEO

Yann D'Herve

CFO

—

Exchange

BSE

Fiscal year

—

Identifiers

· company_identifiers

CIK

CUSIP—

ISININE03QK01018

FIGICOHANCE IB

LEI—

Cross-listings

· companies · ISIN

COHANCE.NSPrimaryNational Stock Exchange of IndiainINR$1.72B
COHANCE.BOBombay Stock ExchangeinINR$1.72B

The global universe keeps only the primary listing; the other venues for this security are shown here.